Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
PHARMACOKINETICS VOLUMES AND PROTEIN BINDING VOLUMES AND PROTEIN BINDING Which of the following alteration in protein binding is likely to be the most clinically significant acutely? A. Volume of distribution=2, fut is increased B. Volume of distribution=150, fut is decreased C. Volume of distribution=2, fut is decreased D. Volume of distribution=150, fup is increased VOLUMES AND PROTEIN BINDING If fup is increased, which of the following situations would most likely require a change in MD? A. Low E drug IV B. Low E drug PO C. High E drug IV D. High E drug PO VOLUMES AND PROTEIN BINDING When do you see a “spike” on the time vs concentration graph (aka transient increase) when fup is increased? A. Both PO and IV Low E drugs B. High E drug given IV C. Only Low E drug given IV D. High E drug given PO E. Both A and D VOLUMES AND PROTEIN BINDING When are you likely to see a clinically significant effect if fup is changed? Low or High protein binding? Wide or narrow therapeutic index? High or Low E drug? IV or PO? VOLUMES AND PROTEIN BINDING Which of the following would result in the most clinically significant (concerning) situation? A. Nonlinear elimination B. Nonlinear plasma protein binding C. Both D. Neither VOLUMES AND PROTEIN BINDING Describe the phases of nonlinear protein binding: DOSE DEPENDENCE DOSE DEPENDENCE CL,T=300 ml/min, fe=0.1. If this drug exhibits non -linear pharmacokinetics, what will be af fected causing an increase in AUC? A. Because B. Because C. Because D. Because it is a high extraction drug, the CL will be affected it is a low extraction drug, the CL will be affected it is a high extraction drug, the F will be affected it is a low extraction drug, the F will be affected. DOSE DEPENDENCE High Extraction Drugs CL= F*= Non-linear PK manifests in: Terminal slope will be: Half life: Low Extraction Drugs CL= F*= Non-linear PK manifests in: Terminal slope will be: Half-life: DOSE DEPENDENCE DOSE DEPENDENCE DOSE DEPENDENCE QUESTIONS?